Phlebotomy a How-To Guide for Drawing Blood

Total Page:16

File Type:pdf, Size:1020Kb

Phlebotomy a How-To Guide for Drawing Blood Allied Health Career Training, LLC Phlebotomy A how-to guide for drawing blood Compiled by: Brandy Thimesch August 2016 / Revised November 2018 TABLE OF CONTENTS Chapter 1. Introduction to Phlebotomy Page 1 Chapter 2. Ethics and Laws Page 15 Chapter 3. Medical Terminology Page 21 Chapter 4. Safety and Infection Control Page 33 Chapter 5. Laboratory Testing Page 43 Chapter 6. Collection Methods Page 51 Chapter 7. Variables and Complications Page 67 Chapter 8. Venipuncture Procedures Page 75 Chapter 9. Indications for Skin Punctures Page 83 Chapter 10. Pediatric & Geriatric Patients Page 89 Chapter 11. Special Collections Page 97 Case Studies Page 107 Common Laboratory Tests Page 113 Terms and Definitions Page 123 NHA Study Guide Page 133 References Page 147 CHAPTER ONE – INTRODUCTION TO PHLEBOTOMY CHAPTER 1. Introduction to Phlebotomy So, you’ve decided you want to become what we jokingly refer to as a certified vampire and draw blood for a living. What is more commonly known as a phlebotomist, these individuals are also known as specimen handlers or blood collectors (but not blood drinkers ). Why is it necessary to draw blood? What do we do with all this body fluid? Well, phlebotomists play a very big part in treating and diagnosing patients. If it wasn’t for lab testing, doctors would just be guessing! Lab results are critical to patient care. Some of the most important aspects of lab tests are: • Diagnostic and screening – to figure out what is wrong with a patient • Therapeutic assessment – to develop the correct treatment or choose right drugs • Monitoring health – to make sure the therapy or treatment is working Phlebotomy Origins The word “phlebotomy” (and most medical terminology) is derived from the Greek language. Phleb – A prefix meaning veins or blood vessels tomy – A suffix meaning to cut or make an incision The most common methods of today for blood collecting are: • venipuncture - withdrawing venous blood sample using a needle. • skin puncture - puncturing the skin (usually on a finger or heel) for a small amount of capillary blood (*Skin punctures are also referred to as dermal sticks, capillary draws, finger sticks, and heel sticks.) The practice of phlebotomy has been documented as far back as the Stone Age. Markings on tombs found in Egypt show men applying leeches for bloodletting purposes. Bloodletting was a common medical practice that extended from those ancient times until the late 19th century, spanning nearly 2,000 years. The death of our country’s first president, George Washington, in 1799 is attributed in part to the several liters of blood that were drawn after he developed an infection from weather exposure. In the early 1900’s it was generally barbers who practiced phlebotomy and also tooth extraction in their shops. This is where the red and white striped barber shop poles come from. The white represented bandages and the red represented blood. Many crude tools and objects have been used over the centuries, but modern medicine has come a long way! 1 CHAPTER ONE – INTRODUCTION TO PHLEBOTOMY Necessary Character Traits There are certain character traits a person needs in order to work in the healthcare field. Some of the most important traits are: • Do not harm anyone intentionally • Ability to perform according to job description and use good judgment • Respect for patients’ rights • Have regard for dignity of all human beings Let’s start with the first one: Do not harm anyone intentionally. When dealing with the public in healthcare, let’s face it: you will not see people at their best. Many of your patients may be dealing with chronic pain or illness, so naturally they may be grumpy. They may take it out on you, or blame you for things that are out of your control. It is not appropriate to cause the phlebotomy procedure to be even more painful just because they might have hurt your ego. Show compassion. When dealing with the public you must not take things personally. Always follow the golden rule: “Treat people the way you would want to be treated.” As a phlebotomist your duties are limited to what is outlined in your job description. Your supervisor and healthcare facility will have a job description for you to follow. This description will comply with state and federal laws. You must be properly trained and adhere to these laws when working in the healthcare field. If an accident occurs while you were working outside of your job description, there could be severe consequences, such as injury to yourself or patients, loss of your job, or lawsuits. When working in a hospital setting you need to be aware of your limitations. This does not mean you should ignore a patient’s needs; always get a nurse or aid to assist them. It will not be in your job description to: • Start IV’s • Administer medications • Transfer patients (this includes helping patients to the restroom) • Feed patients Patients have the right to refuse medical treatment, which includes having their blood drawn. You do not have the right to do any procedure, phlebotomy or otherwise, without the consent of the patient and/or their medical guardian. You must respect the patient’s rights. If a patient should refuse treatment, document the refusal and notify the nurse. When performing a phlebotomy procedure, make sure to do it with as much privacy and regard for the patient’s dignity as possible. It is not appropriate to perform a blood draw on a patient while they are on the toilet or commode. If a patient is being bathed, wait for a better time. Wait for patients to be fully clothed, if at all possible. Patients have the right to dignity and privacy, regardless of their condition. 2 CHAPTER ONE – INTRODUCTION TO PHLEBOTOMY Certification Eligibility After reading about the characteristics needed for working in the healthcare field, let’s talk about the necessary qualifications to become certified as a phlebotomist. To be eligible to sit for the National Healthcareer Association’s CPT (Certified Phlebotomy Technician) Exam you must meet the following criteria: 1. You must have a High School Diploma or GED, OR you must expect to earn a High School Diploma or GED in the next 12 months. 2. You must have successfully performed 30 venipunctures and 10 capillary sticks on live individuals. 3. You must have completed a phlebotomy training program in the past five years. Specimen Testing Phases The process of specimen testing happens in three distinct phases, pre-analytical, analytical, and post-analytical. • Pre-Analytical Phase - A phlebotomist’s duties are part of the pre-analytical and pre- examination phase of testing. Pre-analytical and pre-examination have the same meaning, and refer to specimen collection. This process occurs before actual testing begins and is one of the most important roles in clinical testing. Most mistakes take place in the pre-analytical phase of testing. Things can go from good to very bad in this phase of testing if not done correctly. This phase includes the following: . Correctly identifying the patient and labeling the specimen . Accurately performing the collection . Transporting the specimen(s) to the lab in a timely manner A phlebotomist’s main goal is to assist the healthcare team in accurate, safe, and reliable collection and transportation of specimens for testing. When collecting specimens for testing make sure to identify your patient. It is important for the phlebotomist to be detailed-oriented when performing the tasks. Avoid distractions when labeling, have the patient spell his or her last name and first, and always ask for a date of birth. After obtaining your specimen, clearly label the specimen tube and/or container. Time can be of the essence in healthcare! It is very important to transport the specimen back to the lab in a timely manner. Kind of like delivering a pizza, it must be done in 30 minutes or less! • Analytical Phase - The analytical phase is when testing of the specimen begins; more than likely your laboratory technicians will be involved with this phase (those are the ones in the lab coats). The specimen is transported to the lab and processed, after which testing begins. When the tests are complete the results are given to the doctor. 3 CHAPTER ONE – INTRODUCTION TO PHLEBOTOMY • Post-analytical Phase - Once results from the specimen testing are given to the doctor, the doctor then uses these results to determine a patient’s diagnosis and the patient is treated accordingly. This is why it is important that the patient and specimen are both correctly identified all the way back in the pre-analytical phase. Here is an example of what can happen when errors occur in the process: Mrs. Yappy is being treated for a blood clot. The doctor is treating Mrs. Yappy with a blood thinner. Routine lab tests are ordered every week to make sure her blood is not too thin or thick. One Monday, Mrs. Yappy and Mrs. Happy come to the lab at the same time. The phlebotomist mislabels Mrs. Yappy’s tube with Mrs. Happy’s tube. The specimens are tested and results are given to the doctor. Mrs. Yappy’s blood appears to not be thin enough, so the doctor orders a higher dose of blood thinner. Later in the week Mrs. Yappy ends up in the hospital with internal bleeding because her blood was way too thin. Figure 1 shows an overview of how all three phases work together: 4 CHAPTER ONE – INTRODUCTION TO PHLEBOTOMY Good Standard of Care Which speaks louder, actions or words? Action always speaks louder than words. If you are taking on this job in hopes to be popular, I hate to disappoint you, but no one is excited to see a needle.
Recommended publications
  • Blood Collection
    Blood Collection (Note: Navigation around this large pdf document is best accomplished using the bookmarks function.) 355.1 Preface Blood collection (venipuncture, phlebotomy) is a common and important specimen collection procedure in the conduct of research. In many protocols, multiple blood draws are an important part of collecting and analyzing data. The Emory University Institutional Animal Care and Use Committee (IACUC) developed a policy to best enable blood collection while minimizing the potential for pain, unnecessary stress, distress or untoward effect in research animals. These are articulated by way of this general overview supplemented by companion documents appropriate to certain species. The species-specific sections differentiate from the general standards in being more precise, and sometimes more adaptable, in considering the frequency and total number of blood collection events; maximum collectable volumes allowed based upon specific physiology; detailing allowable routes particular to each species; differentiating between terminal and survival circumstances; disclosing requirements for anesthesia or restraint; scientific qualifiers and addressing conditionally permissible methods or settings germane to a species. This list is not exhaustive and persons requiring information regarding the supplies and equipment needed, specifics of restraint or anesthesia, requirements for ancillary care, habituation requirements, application to study in the field and other information are encouraged to contact the Training Coordinators for their specific site. o DAR Training Request: http://www.dar.emory.edu/forms/training_wrkshp.php o Yerkes National Primate Research Center Training: Jennifer McMillan, [email protected], 404-712-9217 While it only takes about 24 hours for the lost fluid volume of blood to be restored, it takes longer to regeneratively replenish erythrocytes, platelets and other circulating factors.
    [Show full text]
  • Bioimpedance Monitoring System for Pervasive Biomedical Applications
    Bioimpedance monitoring system for pervasive biomedical applications Jaime Punter Villagrasa ADVERTIMENT . La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió d’aquesta tesi per mitjà del servei TDX ( www.tdx.cat ) i a través del Dipòsit Digital de la UB ( diposit.ub.edu ) ha estat autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en ac tivitats d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposici ó des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB . No s’autoritza la presentació del seu contingut en una finestra o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora . ADVERTENCIA . La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La difusión de esta tesis por medio del servicio TDR ( www.tdx.cat ) y a través del Repositorio Digital de la UB ( diposit.ub.edu ) ha sido auto rizada por los titulares de los derechos de propiedad intelectual únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro ni su difusión y puesta a disposición desde un si tio ajeno al servicio TDR o al Repositorio Digital de la UB .
    [Show full text]
  • Digital Vein Mapping Guiding Laser and Injection Sclerotherapy to Treat Telangiectasias and Feeder Veins: Report of 140 Cases
    ARTÍCULO ORIGINAL Digital Vein Mapping Guiding Laser and Injection sclerotherapy to treat telangiectasias and Feeder Veins: Report of 140 Cases. Authors: Roberto Kasuo Miyake, MD, PhD / Rodrigo Kikuchi, MD / Flavio Henrique Duarte, MD / John Davidson, MD / Hiroshi Miyake, MD, PhD Institution: Clinica Miyake, Sao Paulo, Brazil E-Mail autor: [email protected] Fecha recepción artículo: 23/11/2008 - Fecha aceptación artículo: Marzo 2009 Abstract Resumen Background and Objective: Telangiectasias Antecedentes y Objetivo: la ineficiencia en el treatment inefficiency may occur due to tratamiento de las telangiectasias puede deber- invisible feeder veins. These veins can be made se a las venas nutricias no visibles. Estas venas discernible by use of a digital vein detection pueden hacerse perceptibles mediante el uso de device (V-V). This study evaluates a method un dispositivo digital de detección (VV). Este to treat vascular lesions by combining 1064nm estudio evalúa un método para el tratamiento laser, injection sclerotherapy, a skin cooling de lesiones vasculares mediante la combinación device (CLaCS) and the V-V. de láser de 1064nm, la escleroterapia por inyec- Materials and Methods: Patients were treated ción y un dispositivo de enfriamiento de la piel with laser and sclerotherapy, both applied (CLACS, Cryo-Laser y Cryo-Sclerotherapy)) y under cooling. V-V was used to visualize hidden el VV (The VeinViewer™). feeder veins. Material y Métodos: Los pacientes fueron trata- Results: A total of 140 patients underwent dos con láser y la escleroterapia, ambos aplicados CLaCS. In 121 patients (86%) satisfactory bajo enfriamiento con (CLaCS). El dispositivo cosmetic results were obtained avoiding digital V-V se utiliza para visualizar las venas phlebectomy.
    [Show full text]
  • How Do We Treat Life-Threatening Anemia in a Jehovah's Witness
    HOW DO I...? How do we treat life-threatening anemia in a Jehovah’s Witness patient? Joseph A. Posluszny Jr and Lena M. Napolitano he management of Jehovah’s Witness (JW) The refusal of allogeneic human blood and blood prod- patients with anemia and bleeding presents a ucts by Jehovah’s Witness (JW) patients complicates clinical dilemma as they do not accept alloge- the treatment of life-threatening anemia. For JW neic human blood or blood product transfu- patients, when hemoglobin (Hb) levels decrease Tsions.1,2 With increased understanding of the JW patient beyond traditional transfusion thresholds (<7 g/dL), beliefs and blood product limitations, the medical com- alternative methods to allogeneic blood transfusion can munity can better prepare for optimal treatment of severe be utilized to augment erythropoiesis and restore life-threatening anemia in JW patients. endogenous Hb levels. The use of erythropoietin- Lower hemoglobin (Hb) is associated with increased stimulating agents and intravenous iron has been mortality risk in JW patients. In a study of 300 patients shown to restore red blood cell and Hb levels in JW who refused blood transfusion, for every 1 g/dL decrease patients, although these effects may be significantly in Hb below 8 g/dL, the odds of death increased 2.5-fold delayed. When JW patients have evidence of life- (Fig. 1).3 A more recent single-center update of JW threatening anemia (Hb <5 g/dL), oxygen-carrying patients (n = 293) who declined blood transfusion capacity can be supplemented with the administration reported an overall mortality rate of 8.2%, with a twofold of Hb-based oxygen carriers (HBOCs).
    [Show full text]
  • Guidelines for Transfusion and Patient Blood Management, and Discuss Relevant Transfusion Related Topics
    Guidelines for Transfusion and Community Transfusion Committee Patient Blood Management Community Transfusion Committee CHAIR: Aina Silenieks, M.D., [email protected] MEMBERS: A.Owusu-Ansah, M.D. S. Dunder, M.D. M. Furasek, M.D. D. Lester, M.D. D. Voigt, M.D. B. J. Wilson, M.D. COMMUNITY Juliana Cordero, Blood Bank Coordinator, CHI Health Nebraska Heart REPRESENTATIVES: Becky Croner, Laboratory Services Manager, CHI Health St. Elizabeth Mackenzie Gasper, Trauma Performance Improvement, Bryan Medical Center Kelly Gillaspie, Account Executive, Nebraska Community Blood Bank Mel Hanlon, Laboratory Specialist - Transfusion Medicine, Bryan Medical Center Kyle Kapple, Laboratory Quality Manager, Bryan Medical Center Lauren Kroeker, Nurse Manager, Bryan Medical Center Christina Nickel, Clinical Laboratory Director, Bryan Medical Center Rachael Saniuk, Anesthesia and Perfusion Manager, Bryan Medical Center Julie Smith, Perioperative & Anesthesia Services Director, Bryan Medical Center Elaine Thiel, Clinical Quality Improvement/Trans. Safety Officer, Bryan Med Center Kelley Thiemann, Blood Bank Lead Technologist, CHI Health St. Elizabeth Cheryl Warholoski, Director, Nebraska Operations, Nebraska Community Blood Bank Jackie Wright, Trauma Program Manager, Bryan Medical Center CONSULTANTS: Jed Gorlin, M.D., Innovative Blood Resources [email protected] Michael Kafka, M.D., LifeServe Blood Center [email protected] Alex Smith, D.O., LifeServe Blood Center [email protected] Nancy Van Buren, M.D., Innovative
    [Show full text]
  • Reducing the Risk of Iatrogenic Anemia and Catheter-Related Bloodstream Infections Using Closed Blood Sampling
    WHITE PAPER WHITE Reducing the Risk of Iatrogenic Anemia and Catheter-Related Bloodstream Infections Using Closed Blood Sampling INTRODUCTION In the Intensive Care Unit (ICU), critically ill patients are more numerous and severely ill than ever before.1 To effectively care for these patients, clinicians rely on physiologic monitoring of blood-flow, oxygen transport, coagulation, metabolism, and organ function. This type of monitoring has made the collection of blood for testing an essential part of daily management of the critically ill patient, yet it is widely recognized that excessive phlebotomy has a deleterious effect on patient health. The result is a clinical paradox in which diligent care may contribute to iatrogenic anemia. RISKS ASSOCIATED WITH CONVENTIONAL DIAGNOSTIC BLOOD SAMPLING Iatrogenic Anemia The process of obtaining a blood sample from an indwelling central venous or arterial Use of blood sampling techniques that rely catheter requires a volume of diluted blood on discarding a volume of blood for each (2–10 mL) to be discarded or “cleared” from the catheter before a sample can be taken.2,3 sample may contribute to iatrogenic anemia, Studies have shown that patients with central which remains a prevalent issue affecting venous or arterial catheters have more blood sampling than ICU patients who don’t have the vast majority of patients in the ICU. these catheters and the total blood volume drawn from patients with arterial catheters is 44% higher than patients without arterial catheters (See Table 1).4,5 It has also been
    [Show full text]
  • 6.5 X 11 Double Line.P65
    Cambridge University Press 978-0-521-53026-2 - The Cambridge Historical Dictionary of Disease Edited by Kenneth F. Kiple Index More information Name Index A Baillie, Matthew, 80, 113–14, 278 Abercrombie, John, 32, 178 Baillou, Guillaume de, 83, 224, 361 Abreu, Aleixo de, 336 Baker, Brenda, 333 Adams, Joseph, 140–41 Baker, George, 187 Adams, Robert, 157 Balardini, Lodovico, 243 Addison, Thomas, 22, 350 Balfour, Francis, 152 Aesculapius, 246 Balmis, Francisco Xavier, 303 Aetius of Amida, 82, 232, 248 Bancroft, Edward, 364 Afzelius, Arvid, 203 Bancroft, Joseph, 128 Ainsworth, Geoffrey C., 128–32, 132–34 Bancroft, Thomas, 87, 128 Albert, Jose, 48 Bang, Bernhard, 60 Alexander of Tralles, 135 Bannwarth, A., 203 Alibert, Jean Louis, 147, 162, 359 Bard, Samuel, 83 Ali ibn Isa, 232 Barensprung,¨ F. von, 360 Allchin, W. H., 177 Bargen, J. A., 177 Allison, A. C., 25, 300 Barker, William H., 57–58 Allison, Marvin J., 70–71, 191–92 Barthelemy,´ Eloy, 31 Alpert, S., 178 Bartlett, Elisha, 351 Altman, Roy D., 238–40 Bartoletti, Fabrizio, 103 Alzheimer, Alois, 14, 17 Barton, Alberto, 69 Ammonios, 358 Bartram, M., 328 Amos, H. L., 162 Bassereau, Leon,´ 317 Andersen, Dorothy, 84 Bateman, Thomas, 145, 162 Anderson, John, 353 Bateson, William, 141 Andral, Gabriel, 80 Battistine, T., 69 Annesley, James, 21 Baumann, Eugen, 149 Arad-Nana, 246 Beard, George, 106 Archibald, R. G., 131 Beet, E. A., 24, 25 Aretaeus the Cappadocian, 80, 82, 88, 177, 257, 324 Behring, Emil, 95–96, 325 Aristotle, 135, 248, 272, 328 Bell, Benjamin, 152 Armelagos, George, 333 Bell, J., 31 Armstrong, B.
    [Show full text]
  • Diagnostic Blood Loss from Phlebotomy and Hospital-Acquired Anemia During Acute Myocardial Infarction
    ORIGINAL INVESTIGATION ONLINE FIRST |LESS IS MORE Diagnostic Blood Loss From Phlebotomy and Hospital-Acquired Anemia During Acute Myocardial Infarction Adam C. Salisbury, MD, MSc; Kimberly J. Reid, MS; Karen P. Alexander, MD; Frederick A. Masoudi, MD, MSPH; Sue-Min Lai, PhD, MS, MBA; Paul S. Chan, MD, MSc; Richard G. Bach, MD; Tracy Y. Wang, MD, MHS, MSc; John A. Spertus, MD, MPH; Mikhail Kosiborod, MD Background: Hospital-acquired anemia (HAA) during Results: Moderate to severe HAA developed in 3551 pa- acute myocardial infarction (AMI) is associated with tients(20%).Themean(SD)phlebotomyvolumewashigher higher mortality and worse health status and often de- in patients with HAA (173.8 [139.3] mL) vs those without velops in the absence of recognized bleeding. The ex- HAA (83.5 [52.0 mL]; PϽ.001). There was significant varia- tent to which diagnostic phlebotomy, a modifiable pro- tion in the mean diagnostic blood loss across hospitals (mod- cess of care, contributes to HAA is unknown. erate to severe HAA: range, 119.1-246.0 mL; mild HAA or no HAA: 53.0-110.1 mL). For every 50 mL of blood drawn, the risk of moderate to severe HAA increased by 18% (rela- Methods: We studied 17 676 patients with AMI from tiverisk[RR],1.18;95%confidenceinterval[CI],1.13-1.22), 57 US hospitals included in a contemporary AMI data- which was only modestly attenuated after multivariable ad- base from January 1, 2000, through December 31, 2008, justment (RR, 1.15; 95% CI, 1.12-1.18). who were not anemic at admission but developed mod- erate to severe HAA (in which the hemoglobin level de- Conclusions: Blood loss from greater use of phle- Ͻ clined from normal to 11 g/dL), a degree of HAA that botomy is independently associated with the develop- has been shown to be prognostically important.
    [Show full text]
  • Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins
    Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Student Dissertations, Theses and Papers Scholarship 2016 Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins as Compared to Conventional Treatments? Sachi Patel Philadelphia College of Osteopathic Medicine, [email protected] Follow this and additional works at: http://digitalcommons.pcom.edu/pa_systematic_reviews Part of the Cardiovascular Diseases Commons Recommended Citation Patel, Sachi, "Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins as Compared to Conventional Treatments?" (2016). PCOM Physician Assistant Studies Student Scholarship. 291. http://digitalcommons.pcom.edu/pa_systematic_reviews/291 This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Physician Assistant Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For more information, please contact [email protected]. Is Polidocanol foam sclerotherapy effective in treating varicose veins as compared to conventional treatments? Sachi Patel, PA-S A SELECTIVE EVIDENCE BASED MEDICINE REVIEW In Partial Fulfillment of the Requirement for The Degree of Master of Science In Health Sciences- Physician Assistant Department of Physician Assistant Studies Philadelphia College of Osteopathic Medicine Philadelphia, Pennsylvania December 18, 2015 ABSTRACT OBJECTIVE: The objective of this selective EBM review is to determine whether or not Polidocanol foam sclerotherapy is effective in treating varicose veins as compared to conventional treatments. STUDY DESIGN: Review of three randomized controlled trials. All three studies are published in English between 2008 – 2012. DATA SOURCES: Three randomized control trials were found using PubMED and Medline.
    [Show full text]
  • APG Regulations
    FINAL as of 8/22/08 Pursuant to the authority vested in the Commissioner of Health by Section 2807(2-a) of the Public Health Law, Part 86 of Title 10 of the Official Compilation of Codes, Rules and Regulations of the State of New York, is amended by adding a new Subpart 86-8, to be effective upon filing with the Secretary of State, to read as follows: SUBPART 86-8 OUTPATIENT SERVICES: AMBULATORY PATIENT GROUP (Statutory authority: Public Health Law § 2807(2-a)(e)) Sec. 86-8.1 Scope 86-8.2 Definitions 86-8.3 Record keeping, reports and audits 86-8.4 Capital reimbursement 86-8.5 Administrative rate appeals 86-8.6 Rates for new facilities during the transition period 86-8.7 APGs and relative weights 86-8.8 Base rates 86-8.9 Diagnostic coding and rate computation 86-8.10 Exclusions from payment 86-8.11 System updating 86-8.12 Payments for extended hours of operation § 86-8.1 Scope (a) This Subpart shall govern Medicaid rates of payments for ambulatory care services provided in the following categories of facilities for the following periods: (1) outpatient services provided by general hospitals on and after December 1, 2008; (2) emergency department services provided by general hospitals on and after January 1, 2009; (3) ambulatory surgery services provided by general hospitals on and after December 1, 2008; (4) ambulatory services provided by diagnostic and treatment centers on and after March 1, 2009; and (5) ambulatory surgery services provided by free-standing ambulatory surgery centers on and after March 1, 2009.
    [Show full text]
  • Phlebotomy Student Handbook
    LORAIN COUNTY COMMUNITY COLLEGE DIVISION OF HEALTH AND WELLNESS SCIENCES PHLEBOTOMY PROGRAM PHBT STUDENT HANDBOOK 2019-2020 SCHOOL YEAR CHERYL SELVAGE, MS MT(ASCP) Program Director June 2019 PHBT Student Handbook i LORAIN COUNTY COMMUNITY COLLEGE DIVISION OF HEALTH AND WELLNESS SCIENCES PHLEBOTOMY STUDENT HANDBOOK 2019-2020 School Year This handbook does not constitute a contract. The Program faculty reserve the right to revise this handbook at any time. Students will be given information regarding these changes either verbally or in a printed addendum. Prepared by: Cheryl Selvage, MS MT(ASCP) Clinical Laboratory Science Technology / Phlebotomy Program Director August 2019 PHBT Student Handbook ii TABLE OF CONTENTS TOPIC PAGE I. WELCOME ........................................................................................................... 1 II. INTRODUCTION................................................................................................... 1 A. History and Program Approval ....................................................................... 1 III. PURPOSE OF THE PHLEBOTOMY PROGRAM STUDENT HANDBOOK ........... 2 IV. PHILOSOPHY OF THE PHLEBOTOMY PROGRAM ............................................ 2 A. College Mission ............................................................................................... 2 B. Division of Health and Wellness ....................................................................... 3 C. PHBT Program Mission Statement .................................................................
    [Show full text]
  • Downloaded from By
    Downloaded from https://journals.lww.com/anesthesia-analgesia by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3K8IvHCABgh9Yu9L0l5kxZKY/IVIk0VJmMvNDnPGtDFo= on 09/17/2018 Downloaded from https://journals.lww.com/anesthesia-analgesia by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3K8IvHCABgh9Yu9L0l5kxZKY/IVIk0VJmMvNDnPGtDFo= on 09/17/2018 SABM ABSTRACTS 1. Laparoscopic D1+ Lymph Node Dissection for Gastric Cancer in Jehovah’s Witness Patients: A 1:3 Matched Case Control Study ................................................................................................1 2. A Multimodal Approach Reduced Allogeneic Blood Transfusions by Over 50% in Pediatric Posterior Spinal Fusion (PSF) Surgeries ...............................................................................................2 3. A Successful Selective Concurrent Audit of Platelet Utilization in a Large Academic Hospital ��������������������������������������������������4 4. Total Knee Arthroplasty is Safe in Jehovah’s Witness Patients—A 12-year Perspective ................................6 5. Automated Quantification of Blood Loss Versus Visual Estimation: A Prospective Study of 274 Vaginal Deliveries ......7 6. The Little Hospital That Could: Building a Nationally Recognized Patient Blood Management Program ...............8 7. Sickle Red Blood Cells are More Susceptible to In Vitro Hemolysis when Exposed to Normal Saline versus Plasma-Lyte A ...............................................................................................10
    [Show full text]